Practice Impact

Britain aims for millions of COVID-19 tests in months after criticism

Apr 8, 2020

By Alistair Smout LONDON (Reuters) – Britain said on Wednesday it aimed to roll-out millions...

Cytokine Storm: The Sudden Crash in Patients with COVID-19

Apr 8, 2020

It’s jarring every time. The sudden crash in patients with COVID-19 All over the world,...

Obesity is major COVID-19 risk factor, says French chief epidemiologist

Apr 8, 2020

By Geert De Clercq PARIS (Reuters) – Being overweight is a major risk for people infected...

UK coronavirus testing capacity boosted by new AstraZeneca, GSK lab

Apr 8, 2020

LONDON (Reuters) – Britain will have a new coronavirus testing facility capable of carrying...

Successful online management of COVID-19 infection

Apr 8, 2020

New Rochelle, NY, April 6, 2020–A team of researchers in Wuhan, China have developed a...

What cells does the novel coronavirus attack?

Apr 7, 2020

Scientists from the Berlin Institute of Health (BIH), Charité – Universitätsmedizin Berlin...

New guidelines on caring for ICU patients with COVID-19

Apr 7, 2020

International panel does quick turnaround McMaster University Hamilton, ON (April 1, 2020) –...

U.S. DEA relaxes production limits on controlled drugs for COVID-19 patients

Apr 7, 2020

(Reuters) – The U.S. Drug Enforcement Administration said on Tuesday it was increasing production limits by 15% for certain controlled substance medicines that were in high demand due to the COVID-19 pandemic. The...

Special Report: Doctors embrace drug touted by Trump for COVID-19, without hard evidence it works

Apr 7, 2020

By Michael Erman and Deena Beasley NEW YORK/LOS ANGELES (Reuters) – The decades-old drug...

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.

Apr 7, 2020

In December 2019, the Coronavirus disease-2019 (COVID-19) virus has emerged in Wuhan, China. In...

School closures will have little impact on COVID-19 control, review finds

Apr 6, 2020

By Kate Kelland LONDON (Reuters) – School closures do not tend to help contain the spread of...

GSK to partner with Vir for potential COVID-19 treatments, invest $250 million

Apr 6, 2020

By Trisha Roy and Manas Mishra (Reuters) – British drugmaker GlaxoSmithKline will invest...

Experts urge smokers and tobacco firms to quit for COVID-19

Apr 6, 2020

LONDON (Reuters) – Health experts on Monday urged smokers to quit and cigarette companies to...

Majority of Physicians Report Serious Concerns About COVID-19

Apr 6, 2020

National survey shows concerns regarding adequacy of supplies and COVID-19 testing

Extracorporeal Membrane Oxygenation Might Aid in Severe COVID-19

Apr 6, 2020

Three of eight patients receiving ECMO support successfully weaned off ECMO after 22, 40, 47 days

UK’s Izana Bioscience tests rheumatoid arthritis drug in COVID-19 patients

Apr 5, 2020

LONDON (Reuters) – UK-based biopharma company Izana Bioscience said it was testing its antibody therapy namilumab for the treatment of patients with rapidly worsening COVID-19 at the Humanitas Research Hospitals in Bergamo...